Fig. 4From: Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapyStability as function of time of 213Bi-DOTATATE with different concentration ascorbic acid added during labelling, y-axis is RCP expressed in mean percentage ± SD and x-axis time in minutes after labelling (n ≥ 3)Back to article page